278 related articles for article (PubMed ID: 27484511)
1. Aromatic heterocyclic esters of podophyllotoxin exert anti-MDR activity in human leukemia K562/ADR cells via ROS/MAPK signaling pathways.
Zhang L; Zhang Z; Chen F; Chen Y; Lin Y; Wang J
Eur J Med Chem; 2016 Nov; 123():226-235. PubMed ID: 27484511
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of the multidrug resistance-reversing activity of pyridine acid esters of podophyllotoxin in human leukemia cells.
Zhang L; Chen F; Zhang Z; Chen Y; Lin Y; Wang J
Bioorg Med Chem Lett; 2016 Sep; 26(18):4466-4471. PubMed ID: 27503681
[TBL] [Abstract][Full Text] [Related]
3. Chabamide induces cell cycle arrest and apoptosis by the Akt/MAPK pathway and inhibition of P-glycoprotein in K562/ADR cells.
Ren J; Xu Y; Huang Q; Yang J; Yang M; Hu K; Wei K
Anticancer Drugs; 2015 Jun; 26(5):498-507. PubMed ID: 25714087
[TBL] [Abstract][Full Text] [Related]
4. PHII-7 inhibits cell growth and induces apoptosis in leukemia cell line K562 as well as its MDR- counterpart K562/A02 through producing reactive oxygen species.
Peng H; Yuan X; Shi R; Wei X; Ren S; Yan C; Ding Y; Lin Y; Fan D; Yang M; Zhang Y; Xiong D
Eur J Pharmacol; 2013 Oct; 718(1-3):459-68. PubMed ID: 23911883
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and antineoplastic activity of novel hybrids of podophyllotoxin and indirubin against human leukaemia cancer cells as multifunctional anti-MDR agents.
Wang J; Long L; Chen Y; Xu Y; Zhang L
Bioorg Med Chem Lett; 2018 Jun; 28(10):1817-1824. PubMed ID: 29678463
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of novel podophyllotoxin derivatives as potential antitumor agents.
Cheng WH; Cao B; Shang H; Niu C; Zhang LM; Zhang ZH; Tian DL; Zhang S; Chen H; Zou ZM
Eur J Med Chem; 2014 Oct; 85():498-507. PubMed ID: 25113878
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of a novel artesunate-podophyllotoxin conjugate as anticancer agent.
Zhang L; Chen F; Zhang Z; Chen Y; Wang J
Bioorg Med Chem Lett; 2016 Jan; 26(1):38-42. PubMed ID: 26615886
[TBL] [Abstract][Full Text] [Related]
8. The Hsp90 inhibitor SNX-2112, induces apoptosis in multidrug resistant K562/ADR cells through suppression of Akt/NF-κB and disruption of mitochondria-dependent pathways.
Wang R; Shao F; Liu Z; Zhang J; Wang S; Liu J; Liu H; Chen H; Liu K; Xia M; Wang Y
Chem Biol Interact; 2013 Sep; 205(1):1-10. PubMed ID: 23777986
[TBL] [Abstract][Full Text] [Related]
9. Targeting P-glycoprotein and SORCIN: Dihydromyricetin strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and Ca
Sun Y; Wang C; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Peng J; Liu K
J Cell Physiol; 2018 Apr; 233(4):3066-3079. PubMed ID: 28681913
[TBL] [Abstract][Full Text] [Related]
10. Paris saponin VII induces cell cycle arrest and apoptosis by regulating Akt/MAPK pathway and inhibition of P-glycoprotein in K562/ADR cells.
Yan T; Hu G; Wang A; Sun X; Yu X; Jia J
Phytother Res; 2018 May; 32(5):898-907. PubMed ID: 29377384
[TBL] [Abstract][Full Text] [Related]
11. Picropodophyllotoxin Induces G1 Cell Cycle Arrest and Apoptosis in Human Colorectal Cancer Cells via ROS Generation and Activation of p38 MAPK Signaling Pathway.
Lee SO; Kwak AW; Lee MH; Seo JH; Cho SS; Yoon G; Chae JI; Joo SH; Shim JH
J Microbiol Biotechnol; 2021 Dec; 31(12):1615-1623. PubMed ID: 34528917
[TBL] [Abstract][Full Text] [Related]
12. Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis.
Wang W; Niu S; Qiao L; Wei F; Yin J; Wang S; Ouyang Y; Chen D
Biomed Res Int; 2019; 2019():8727935. PubMed ID: 30886864
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel podophyllotoxin-NSAIDs conjugates as multifunctional anti-MDR agents against resistant human hepatocellular carcinoma Bel-7402/5-FU cells.
Zhang L; Liu L; Zheng C; Wang Y; Nie X; Shi D; Chen Y; Wei G; Wang J
Eur J Med Chem; 2017 May; 131():81-91. PubMed ID: 28301815
[TBL] [Abstract][Full Text] [Related]
14. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
[TBL] [Abstract][Full Text] [Related]
15. Reversal of human multi-drug resistance leukaemic cells by stemofoline derivatives via inhibition of P-glycoprotein function.
Umsumarng S; Pitchakarn P; Sastraruji K; Yodkeeree S; Ung AT; Pyne SG; Limtrakul P
Basic Clin Pharmacol Toxicol; 2015 May; 116(5):390-7. PubMed ID: 25265513
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol Increases Anti-Proliferative Activity of Bestatin Through Downregulating P-Glycoprotein Expression Via Inhibiting PI3K/Akt/mTOR Pathway in K562/ADR Cells.
Wang L; Wang C; Jia Y; Liu Z; Shu X; Liu K
J Cell Biochem; 2016 May; 117(5):1233-9. PubMed ID: 26460589
[TBL] [Abstract][Full Text] [Related]
17. A novel podophyllotoxin derivative (YB-1EPN) induces apoptosis and down-regulates express of P-glycoprotein in multidrug resistance cell line KBV200.
Chen H; Bi W; Cao B; Yang Z; Chen S; Shang H; Yu P; Yang J
Eur J Pharmacol; 2010 Feb; 627(1-3):69-74. PubMed ID: 19879873
[TBL] [Abstract][Full Text] [Related]
18. In vitro anti-leukemia activity of dual PI3K/mTOR inhibitor Voxtalisib on HL60 and K562 cells, as well as their multidrug resistance counterparts HL60/ADR and K562/A02 cells.
Zhang L; Wang Z; Khishignyam T; Chen T; Zhou C; Zhang Z; Jin M; Wang R; Qiu Y; Kong D
Biomed Pharmacother; 2018 Jul; 103():1069-1078. PubMed ID: 29710665
[TBL] [Abstract][Full Text] [Related]
19. Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways.
Zuo D; Zhou Z; Wang H; Zhang T; Zang J; Yin F; Sun W; Chen J; Duan L; Xu J; Wang Z; Wang C; Lin B; Fu Z; Liao Y; Li S; Sun M; Hua Y; Zheng L; Cai Z
J Cell Mol Med; 2017 Feb; 21(2):208-221. PubMed ID: 27624867
[TBL] [Abstract][Full Text] [Related]
20. Dioscin suppresses human laryngeal cancer cells growth via induction of cell-cycle arrest and MAPK-mediated mitochondrial-derived apoptosis and inhibition of tumor invasion.
Si L; Zheng L; Xu L; Yin L; Han X; Qi Y; Xu Y; Wang C; Peng J
Eur J Pharmacol; 2016 Mar; 774():105-17. PubMed ID: 26849940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
